Your prediction
Pros and Cons of CSL Ltd in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CSL Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CSL Ltd | 1.970% | -1.468% | 6.803% | -37.600% | 5.522% | -47.020% | -39.781% |
| Grifols S.A. | -0.720% | 1.421% | -1.426% | 32.837% | 1.236% | -15.540% | -53.529% |
| Incyte Corp. | -0.390% | 0.857% | 0.554% | 21.790% | 3.396% | 12.492% | 12.608% |
| Regeneron Pharmaceuticals Inc. | -0.750% | -0.156% | -3.290% | -1.233% | -3.378% | -6.847% | 54.391% |
News
This Growth Stock Is Building Its Case to Smart Investors
There's a boom going on in much of the U.S., and it's not just tied to technology. Housing shortages have spurred residential homebuilding activity, particularly in fast-growing areas like the Sun
Flu Season's Here—This Dividend-Payer Controls the Shot Market
Last year wasn’t kind to the health care sector. That corner of the market, which includes Big Pharma mainstays such as Eli Lilly (NYSE: LLY), Johnson & Johnson (NYSE: JNJ), and AbbVie (NYSE:
